MassMutual Private Wealth & Trust’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $70K | Buy |
|
|||||
|
2025
Q2 | $61.8K | Sell |
|
|||||
|
2025
Q1 | $61.7K | Buy |
|
|||||
|
2024
Q4 | $72.5K | Buy |
|
|||||
|
2024
Q3 | $43.1K | Sell |
|
|||||
|
2024
Q2 | $70.5K | Buy |
|
|||||
|
2024
Q1 | $49.2K | Buy |
|
|||||
|
2023
Q4 | $45.6K | Buy |
|
|||||
|
2023
Q3 | $37.9K | Buy |
|
|||||
|
2023
Q2 | $23.7K | Buy |
|
|||||
|
2023
Q1 | $18.1K | Buy |
|
|||||
|
2022
Q4 | $20K | Buy |
|
|||||
|
2022
Q3 | $17K | Buy |
|
|||||
|
2022
Q2 | $6K | Sell |
|
|||||
|
2022
Q1 | $7K | Buy |
|
|||||
|
2021
Q4 | $1K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $433 | Sell |
|
|||||
|
2016
Q4 | $2.52K | Buy |
|
|||||
|
2016
Q2 | $221K | Buy |
|
|||||
|
2016
Q1 | $189K | Buy |
|